Related Experiment Video
Updated: May 12, 2026

19:16
The Importance of Correct Protein Concentration for Kinetics and Affinity Determination in Structure-function Analysis
Published on: March 17, 2010
21.1K
Computational design of cysteine proteases.
Biorxiv : the Preprint Server for Biology
|December 3, 2025
Summary
Scientists designed novel enzymes using deep learning to break down peptide bonds. This breakthrough achieves significant rate enhancements, opening doors for new biotechnical and medical applications.
Area of Science:
- Biochemistry
- Enzyme Engineering
- Computational Biology
Background:
- Enzyme design has advanced, but challenges remain for reactions with high energy barriers, like polypeptide hydrolysis.
- Amide bonds in proteins are highly stable due to a significant energy barrier to hydrolysis, persisting for centuries in aqueous solutions.
Purpose of the Study:
- To de novo design enzymes capable of hydrolyzing the polypeptide backbone with high efficiency and sequence specificity.
- To leverage a novel deep learning method for creating enzymes with unique structures distinct from natural proteases.
Main Methods:
- Utilized a new deep learning method, RFD2-MI, for de novo enzyme design.
- Engineered enzymes employing an activated cysteine nucleophile to catalyze polypeptide backbone hydrolysis.
- Validated enzyme designs through structural analysis, comparing crystal structures to computational models.
Main Results:
- Achieved rate enhancements (kcat/kuncat) of up to 3 × 10^7 for polypeptide hydrolysis.
- Designed enzymes with novel folds dissimilar to natural proteases (TM-score < 0.50).
- Demonstrated high accuracy in design methodology with crystal structures closely matching designed models (Cα RMSDs < 1.2 Å).
Conclusions:
- The deep learning approach successfully generated novel enzymes with significant catalytic activity for polypeptide hydrolysis.
- The designed enzymes possess unique structural folds, distinct from those found in nature.
- This methodology holds broad potential for developing new proteases for biotechnological and medical applications.

